BI Asset Management Fondsmaeglerselskab A S Has $1.69 Million Stock Holdings in Waters Corporation $WAT

BI Asset Management Fondsmaeglerselskab A S raised its stake in Waters Corporation (NYSE:WAT) by 82.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,670 shares of the medical instruments supplier’s stock after buying an additional 2,559 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Waters were worth $1,689,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC grew its holdings in shares of Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC raised its holdings in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after buying an additional 30 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after acquiring an additional 6,976 shares during the last quarter. Empowered Funds LLC grew its holdings in Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after acquiring an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in Waters in the 2nd quarter valued at approximately $232,000. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Piper Sandler initiated coverage on shares of Waters in a research note on Thursday, June 11th. They set a “neutral” rating and a $400.00 price target for the company. Evercore upgraded Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price objective for the company in a report on Monday, April 6th. TD Cowen raised their target price on Waters from $345.00 to $385.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. The Goldman Sachs Group raised Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research report on Monday, April 20th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $394.56.

Waters Stock Up 3.2%

Shares of Waters stock opened at $368.70 on Thursday. Waters Corporation has a one year low of $275.05 and a one year high of $414.15. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13. The stock’s 50-day moving average is $345.08 and its 200 day moving average is $347.45. The firm has a market cap of $36.20 billion, a price-to-earnings ratio of 46.85, a PEG ratio of 2.16 and a beta of 1.21.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the prior year, the business earned $2.25 EPS. The company’s revenue for the quarter was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Equities research analysts anticipate that Waters Corporation will post 14.51 EPS for the current year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.